GLOCKNER-10
[pdf-embedder url="https://davipharm.info/wp-content/uploads/GLOCKNER-510_03.pdf"]GLOCKNER-5
Symptomatic treatment of thyrotoxicosis (including Graves-Basedow’ disease). Treatment of hyperthyroidism in preparation for thyroidectomy until the basal metabolism rate return to normal to prevent possible…GOMES
[pdf-embedder url="https://davipharm.info/wp-content/uploads/GOMES_0117.T1.pdf"]GON SA ATZETI
Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due…GON SA EZETI-10
Primary Hypercholesterolaemia: Ezetimibe co-administered with an HMG-CoA reductase inhibitor (statin) is indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial…GONZALEZ-250
[pdf-embedder url="https://davipharm.info/wp-content/uploads/GONZALEZ-125250_0432.T1.pdf"]GONZALEZ-500
[pdf-embedder url="https://davipharm.info/wp-content/uploads/GONZALEZ-500_0433.T1.pdf"]GOURCUFF-2.5
Treatment of the functional symptoms of benign prostatic hyperplasia (BPH). This is only the preview. Please check here for the full indication.GOURCUFF-5
Treatment of the functional symptoms of benign prostatic hyperplasia (BPH). This is only the preview. Please check here for the full indication.GREGORY-2
[pdf-embedder url="https://davipharm.info/wp-content/uploads/GREGORY_03.pdf"]GREGORY-4
[pdf-embedder url="https://davipharm.info/wp-content/uploads/GREGORY_03-1.pdf"]GUARENTE-16
[pdf-embedder url="https://davipharm.info/wp-content/uploads/GUARENTE_01.pdf"]
Davipharm
